Drug: Psilocybin: chronic pain clinical trials
Registry records that list "Drug: Psilocybin" as an intervention. Being studied does not mean an intervention works or is approved.
1
Trials with Canadian sites
1
Recruiting in Canada
8
Registry records in total
Trials in Canada
1 trial, 1 recruiting or not yet recruiting. Recruiting first.
| Phase | Provinces | ||||
|---|---|---|---|---|---|
| Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN NCT06731335 | Recruiting | Phase 2 | Ontario | Unity Health Toronto | 2025-03-05 |
Trials worldwide (outside Canada)
7 trials, 3 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| The Impact of Psilocybin on Pain in Fibromyalgia Patients NCT06368492 | Recruiting | Not applicable | Netherlands | Maastricht University | 2024-05-03 |
| Psilocybin in Chronic Low Back Pain and Depression NCT06355414 | Recruiting | Phase 1 | United States | Johns Hopkins University | 2024-04-22 |
| Psilocybin-facilitated Treatment for Chronic Pain NCT05068791 | Recruiting | Early phase 1 | United States | University of Alabama at Birmingham | 2023-11-01 |
| Psilocybin With Intracranial Neural Sensing NCT06919640 | Enrolling by invitation | Phase 1 | United States | Joshua Woolley, MD, PhD | 2025-06-01 |
| Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain NCT05506982 | Completed | Phase 1 | United States | Emory University | 2022-11-01 |
| Psilocybin-assisted Therapy for Phantom Limb Pain NCT05224336 | Active, not recruiting | Phase 1 | United States | University of California, San Diego | 2022-10-03 |
| Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action NCT05548075 | Unknown status | United Kingdom | Imperial College London | 2022-08-15 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.